China Universal Asset Management Company’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TVTX
SIMG
EA
N
EMFAT
PAM
China Universal Asset Management Company's TVTX Position: Q2 2026 in Review
China Universal Asset Management Company reduced its Travere Therapeutics (TVTX) stake by 25% in Q2 2026, selling an estimated $223K and leaving 14,800 shares worth $841K. The position accounts for 0.05% of the portfolio, ranked #220.
China Universal Asset Management Company first reported a position in TVTX in Q3 2022 and has held it in 16 quarters since. 169 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.
- China Universal Asset Management Company held 14,800 shares of Travere Therapeutics worth $841K as of Q2 2026.
- China Universal Asset Management Company sold 5,025 Travere Therapeutics shares in Q2 2026, an estimated $223K.
- Travere Therapeutics made up 0.05% of China Universal Asset Management Company's portfolio in Q2 2026, its #220 holding.
- China Universal Asset Management Company first reported a position in Travere Therapeutics in Q3 2022 and has held it in 16 quarters since.
- 169 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.